image
TG Therapeutics, Inc. TGTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 29.54
-4.23 %
$ 4.6 B
Market Cap
-295.4
P/E
INCOME STATEMENT
234 M REVENUE
8290.02%
Growth Rates
1Year 8290.02%
3Years 1054.11%
5Years 333.86%
7Years 185.16%
10Years 108.24%
20.6 M OPERATING INCOME
110.70%
Growth Rates
1Year 110.70%
3Years 27.56%
5Years 16.20%
7Years 12.36%
10Years 11.23%
12.7 M NET INCOME
106.39%
Growth Rates
1Year 106.39%
3Years 26.94%
5Years 15.70%
7Years 11.64%
10Years 10.11%
EFFICIENCY
Earnings Waterfall TG Therapeutics, Inc.
image
Revenue 234 M
Cost Of Revenue 14.6 M
Gross Profit 219 M
Operating Expenses 198 M
Operating Income 20.6 M
Other Expenses 7.96 M
Net Income 12.7 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
REVENUE
Revenue 233.7 2.8 6.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 19 K 0 0 0 0 0 0 0 0 0 0.5 2.7 5.4 1.2 3.0 100 K 100 K
GROSS PROFIT
Cost Of Revenue 14.6 0.3 0.8 0.4 0.3 88 K 82.4 K 63 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 4.1 0.8 (0.2) 100 K 0
Gross Profit 219.1 2.5 5.9 (0.2) (0.1) 64 K 70 K 89.4 K 0.2 0.2 0.2 19 K 0 0 0 0 0 0 0 0 0 0.5 0.6 1.3 0.4 3.2 0.2 100 K
OPERATING INCOME
Operating Expenses 198.5 195.4 350.7 273.7 169.2 174.6 118.9 79.1 63.3 55.9 20.3 25.8 0.9 2.0 1.8 4.4 12.1 10.0 19.4 6.1 4.8 2.1 3.7 4.5 3.1 5.9 5.5 3.9
Selling, General and Administrative Expenses 122.3 83.2 152.1 121.8 20.8 20.8 22.0 12.6 19.9 24.5 7.7 5.2 0.6 1.5 1.7 2.6 3.6 3.8 2.3 2.0 1.8 1.5 2.9 3.3 1.9 2.7 2.8 2.8
Research and Development Expenses 76.2 112.1 198.5 151.9 148.4 153.8 96.9 66.5 43.4 31.4 12.6 20.6 0.3 0.5 40.4 K 1.8 8.5 6.2 17.1 4.2 1.7 0.5 0.9 1.1 1.1 3.0 2.6 1.1
Operating Income 20.6 (192.8) (344.8) (273.6) (169.1) (174.4) (118.7) (79.0) (63.2) (55.7) (23.0) (26.9) (0.9) (2.0) (1.8) (4.4) (12.1) (10.0) (19.4) (6.1) (4.8) (1.6) (3.1) (3.2) (2.7) (2.7) (5.3) (3.8)
PRE-TAX INCOME
Interest Income Expense 12.6 10.2 5.6 6.3 5.3 1.7 1.1 0 1.0 0.9 1.0 0.9 7.1 K 1.3 0.5 64.8 K 476 1.66 K 0 0 0 0 0 0 0 0 0 0
Total Other Income (7.6) (5.5) (3.3) (5.8) (3.8) 0.9 0.2 0.7 0.2 60.2 K (0.3) 62.6 K 7.1 K 3.4 (0.5) 0.4 0.1 1 K 5.85 K 71.2 K (2.5) (0.5) 1.3 (2.7) 0 0 0.2 0.2
Pre-Tax Income 13.1 (198.3) (348.1) (279.4) (172.9) (173.5) (118.5) (78.3) (62.9) (55.8) (20.5) (25.9) (0.9) 1.3 (2.8) (4.7) (12.0) (10.0) (19.4) (6.1) (7.2) (1.6) (1.8) (5.9) 0 0 (5.1) (3.6)
NET INCOME
Tax Provision 0.4 5.5 7.5 6.5 6.5 (0.9) (0.2) (0.7) (0.2) 60.2 K (2.5) 0.3 36 K (2.6) 1.0 (0.1) (0.1) (0.3) (0.2) (0.2) 1.2 5.98 K (1.4) 2.6 (0.3) 100 K 100 K (0.2)
Net Income 12.7 (203.8) (355.6) (285.9) (179.3) (173.5) (118.5) (78.3) (62.9) (55.8) (20.5) (18.1) (0.9) 0.6 (2.8) (4.3) (12.0) (9.7) (19.1) (5.9) (6.0) (1.5) (1.7) (5.8) (2.4) (2.8) (5.2) (3.6)
EPS 0.0893 1.51 2.69 2.48 2.03 2.3 1.91 1.6 1.38 1.64 0.81 1.38 0.44 15.7 111 170 498 454 1.24 K 616 749 348 1.53 K 13.3 K 7.02 K 8.75 K 23.9 K 17.4 K